SEC Says Ex-Allarity Execs Concealed Doomed FDA Approval
By Katryna Perera · March 12, 2025, 8:53 PM EDT
The U.S. Securities and Exchange Commission sued three former executives of clinical-stage pharmaceutical company Allarity Therapeutics Inc. in Massachusetts federal court, alleging Wednesday that they schemed to conceal from the public...
To view the full article, register now.